Review



goat polyclonal anti oct4  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems goat polyclonal anti oct4
    Goat Polyclonal Anti Oct4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 108 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat polyclonal anti oct4/product/R&D Systems
    Average 95 stars, based on 108 article reviews
    goat polyclonal anti oct4 - by Bioz Stars, 2026-05
    95/100 stars

    Images



    Similar Products

    95
    R&D Systems goat polyclonal anti oct4
    Goat Polyclonal Anti Oct4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat polyclonal anti oct4/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    goat polyclonal anti oct4 - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    96
    R&D Systems af2018 rrid ab 355110 goat polyclonal anti oct4
    Af2018 Rrid Ab 355110 Goat Polyclonal Anti Oct4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/af2018 rrid ab 355110 goat polyclonal anti oct4/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    af2018 rrid ab 355110 goat polyclonal anti oct4 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology polyclonal goat anti-human oct4
    Polyclonal Goat Anti Human Oct4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal goat anti-human oct4/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    polyclonal goat anti-human oct4 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology goat anti-human oct4 polyclonal antibodies sc8628
    (A) Experimental procedure to produce <t>OCT4</t> KO embryos through SCNT. (B) Single guide RNA (sgRNA) design to mutate exon 2 of OCT4; biallelic deletion of single nucleotide in OCT4KOtm1; and maintained SNP. (C) PCA of transcriptome profiles from individual day 7 OCT4KOtm1 (n = 5), NT Ctrl (n = 3), and IVP Ctrl blastocysts (n = 3). PC1, principal component 1; PC2, principal component 2. (D) Venn diagram of differentially abundant transcripts (DATs) identified by DESeq2 analysis of the NT Ctrl vs. IVP Ctrl, OCT4KOtm1 vs. NT Ctrl, and OCT4KOtm1 vs. IVP Ctrl blastocyst transcriptome data. (E) Heat map of DATs from DESeq2 [n = 625; adjusted P value (Padj) < 0.05]. (F) Heat map of genes specific for EPI (blue), HB (red), and TE (green); asterisks indicate DATs at Padj < 0.05.
    Goat Anti Human Oct4 Polyclonal Antibodies Sc8628, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti-human oct4 polyclonal antibodies sc8628/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    goat anti-human oct4 polyclonal antibodies sc8628 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    95
    R&D Systems goat polyclonal anti oct4 antibody
    ( a – c ) The number of cells after dinaciclib treatment. Cell number in 49 fields (7 × 7) was calculated and shown in the graph (n = 4). ( a ) Total cell number. **p < 0.01 vs control. ( b ) Number of <t>OCT4</t> <t>positive</t> cells. **p < 0.01 vs control. ( c ) Number of OCT4 negative cells. n.s., not significant. ( d ) The percentage of OCT4 positive cells. **p < 0.01 vs control. *p < 0.05 vs 6 nM. ( e ) Representative images of OCT4 positive cells (red). Nuclei were stained with Hoechst (blue). Scale bars = 200 μm.
    Goat Polyclonal Anti Oct4 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat polyclonal anti oct4 antibody/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    goat polyclonal anti oct4 antibody - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    95
    R&D Systems polyclonal goat anti human oct4 antibody
    ( a – c ) The number of cells after dinaciclib treatment. Cell number in 49 fields (7 × 7) was calculated and shown in the graph (n = 4). ( a ) Total cell number. **p < 0.01 vs control. ( b ) Number of <t>OCT4</t> <t>positive</t> cells. **p < 0.01 vs control. ( c ) Number of OCT4 negative cells. n.s., not significant. ( d ) The percentage of OCT4 positive cells. **p < 0.01 vs control. *p < 0.05 vs 6 nM. ( e ) Representative images of OCT4 positive cells (red). Nuclei were stained with Hoechst (blue). Scale bars = 200 μm.
    Polyclonal Goat Anti Human Oct4 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal goat anti human oct4 antibody/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    polyclonal goat anti human oct4 antibody - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    Image Search Results


    (A) Experimental procedure to produce OCT4 KO embryos through SCNT. (B) Single guide RNA (sgRNA) design to mutate exon 2 of OCT4; biallelic deletion of single nucleotide in OCT4KOtm1; and maintained SNP. (C) PCA of transcriptome profiles from individual day 7 OCT4KOtm1 (n = 5), NT Ctrl (n = 3), and IVP Ctrl blastocysts (n = 3). PC1, principal component 1; PC2, principal component 2. (D) Venn diagram of differentially abundant transcripts (DATs) identified by DESeq2 analysis of the NT Ctrl vs. IVP Ctrl, OCT4KOtm1 vs. NT Ctrl, and OCT4KOtm1 vs. IVP Ctrl blastocyst transcriptome data. (E) Heat map of DATs from DESeq2 [n = 625; adjusted P value (Padj) < 0.05]. (F) Heat map of genes specific for EPI (blue), HB (red), and TE (green); asterisks indicate DATs at Padj < 0.05.

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: OCT4/POU5F1 is required for NANOG expression in bovine blastocysts

    doi: 10.1073/pnas.1718833115

    Figure Lengend Snippet: (A) Experimental procedure to produce OCT4 KO embryos through SCNT. (B) Single guide RNA (sgRNA) design to mutate exon 2 of OCT4; biallelic deletion of single nucleotide in OCT4KOtm1; and maintained SNP. (C) PCA of transcriptome profiles from individual day 7 OCT4KOtm1 (n = 5), NT Ctrl (n = 3), and IVP Ctrl blastocysts (n = 3). PC1, principal component 1; PC2, principal component 2. (D) Venn diagram of differentially abundant transcripts (DATs) identified by DESeq2 analysis of the NT Ctrl vs. IVP Ctrl, OCT4KOtm1 vs. NT Ctrl, and OCT4KOtm1 vs. IVP Ctrl blastocyst transcriptome data. (E) Heat map of DATs from DESeq2 [n = 625; adjusted P value (Padj) < 0.05]. (F) Heat map of genes specific for EPI (blue), HB (red), and TE (green); asterisks indicate DATs at Padj < 0.05.

    Article Snippet: For OCT4/CDX2 staining, dilutions of goat anti-human OCT4 polyclonal antibodies (SC8628; Santa Cruz) and rabbit anti-human CDX2 polyclonal antibodies (ab88129; Abcam) were 1:500 and 1:250, respectively.

    Techniques:

    Representative confocal planes of day 5 morulae stained for OCT4/CDX2 (Left) and NANOG/GATA6 (Right) from OCT4KOtm1, NT Ctrl, and IVP Ctrl embryos. Sample sizes of OCT4/CDX2 and NANOG/GATA6 were n = 6, 3, and 10 and n = 9, 14, and 7 for OCT4KOtm1, NT Ctrl, and IVP Ctrl, respectively. (Scale bars, 100 µm.)

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: OCT4/POU5F1 is required for NANOG expression in bovine blastocysts

    doi: 10.1073/pnas.1718833115

    Figure Lengend Snippet: Representative confocal planes of day 5 morulae stained for OCT4/CDX2 (Left) and NANOG/GATA6 (Right) from OCT4KOtm1, NT Ctrl, and IVP Ctrl embryos. Sample sizes of OCT4/CDX2 and NANOG/GATA6 were n = 6, 3, and 10 and n = 9, 14, and 7 for OCT4KOtm1, NT Ctrl, and IVP Ctrl, respectively. (Scale bars, 100 µm.)

    Article Snippet: For OCT4/CDX2 staining, dilutions of goat anti-human OCT4 polyclonal antibodies (SC8628; Santa Cruz) and rabbit anti-human CDX2 polyclonal antibodies (ab88129; Abcam) were 1:500 and 1:250, respectively.

    Techniques: Staining

    Representative confocal plane of day 7 blastocysts stained against OCT4/CDX2 (Left) and NANOG/GATA6 (Right) from OCT4KOtm1, NT Ctrl, and IVP Ctrl embryos. Sample sizes of OCT4/CDX2 and NANOG/GATA6 were n = 24, 20, and 40 and n = 21, 23, and 9 for OCT4KOtm1, NT Ctrl, and IVP Ctrl, respectively. (Scale bars, 100 µm.)

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: OCT4/POU5F1 is required for NANOG expression in bovine blastocysts

    doi: 10.1073/pnas.1718833115

    Figure Lengend Snippet: Representative confocal plane of day 7 blastocysts stained against OCT4/CDX2 (Left) and NANOG/GATA6 (Right) from OCT4KOtm1, NT Ctrl, and IVP Ctrl embryos. Sample sizes of OCT4/CDX2 and NANOG/GATA6 were n = 24, 20, and 40 and n = 21, 23, and 9 for OCT4KOtm1, NT Ctrl, and IVP Ctrl, respectively. (Scale bars, 100 µm.)

    Article Snippet: For OCT4/CDX2 staining, dilutions of goat anti-human OCT4 polyclonal antibodies (SC8628; Santa Cruz) and rabbit anti-human CDX2 polyclonal antibodies (ab88129; Abcam) were 1:500 and 1:250, respectively.

    Techniques: Staining

    ( a – c ) The number of cells after dinaciclib treatment. Cell number in 49 fields (7 × 7) was calculated and shown in the graph (n = 4). ( a ) Total cell number. **p < 0.01 vs control. ( b ) Number of OCT4 positive cells. **p < 0.01 vs control. ( c ) Number of OCT4 negative cells. n.s., not significant. ( d ) The percentage of OCT4 positive cells. **p < 0.01 vs control. *p < 0.05 vs 6 nM. ( e ) Representative images of OCT4 positive cells (red). Nuclei were stained with Hoechst (blue). Scale bars = 200 μm.

    Journal: Scientific Reports

    Article Title: Dinaciclib potently suppresses MCL-1 and selectively induces the cell death in human iPS cells without affecting the viability of cardiac tissue

    doi: 10.1038/srep45577

    Figure Lengend Snippet: ( a – c ) The number of cells after dinaciclib treatment. Cell number in 49 fields (7 × 7) was calculated and shown in the graph (n = 4). ( a ) Total cell number. **p < 0.01 vs control. ( b ) Number of OCT4 positive cells. **p < 0.01 vs control. ( c ) Number of OCT4 negative cells. n.s., not significant. ( d ) The percentage of OCT4 positive cells. **p < 0.01 vs control. *p < 0.05 vs 6 nM. ( e ) Representative images of OCT4 positive cells (red). Nuclei were stained with Hoechst (blue). Scale bars = 200 μm.

    Article Snippet: For immunocytochemistry: mouse monoclonal anti-cardiac troponin T antibody (cTnT; Thermo Scientific, Rockford, IL, USA), goat polyclonal anti-OCT4 antibody (R&D systems, Minneapolis, MN, USA), rabbit polyclonal anti-Ki67 antibody (Abcam, Cambridge, UK).

    Techniques: Control, Staining